<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39407332</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2040-2392</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>Molecular autism</Title><ISOAbbreviation>Mol Autism</ISOAbbreviation></Journal><ArticleTitle>Developmental trajectories in infants and pre-school children with Neurofibromatosis 1.</ArticleTitle><Pagination><StartPage>45</StartPage><MedlinePgn>45</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">45</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13229-024-00621-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Children with Neurofibromatosis 1 (NF1) show cognitive, behavioural and social differences compared to their peers. However, the age and sequence at which these differences begin to emerge is not fully understood. This prospective cohort study examines the cognitive, behavioural, ADHD trait and autism symptom development in infant and pre-school children with NF1 compared with typically developing (TD) children without a family history of neurodevelopmental conditions.</AbstractText><AbstractText Label="METHODS">Data from standardised tests was gathered at 5, 10, 14, 24 and 36 months of age (NF1 n = 35, TD n = 29). Developmental trajectories of cognitive (Mullen Scales of Early Learning, MSEL) and adaptive behavioural (Vineland Adaptive Behavior Scales, VABS) development from 5 to 36 months were analysed using linear mixed modelling. Measures of ADHD (Child Behavior Checklist) and autism traits (ADOS-2, BOSA-MV and ADI-R) were assessed at 24 and 36 months.</AbstractText><AbstractText Label="RESULTS">The developmental trajectory of cognitive skills (all domains of the MSEL) and behavioural skills (four domains of the VABS) differed significantly between NF1 and TD groups. Post-hoc tests demonstrated that the NF1 participants scored significantly lower than TD participants at 24 months on all MSEL and VABS domains. The NF1 cohort demonstrated higher mean autism and ADHD traits at 24 months and 14% of the NF1 cohort met a research diagnostic classification for autism at 36 months.</AbstractText><AbstractText Label="LIMITATIONS">The study has a relatively small sample size due to variable retention and rolling recruitment. Due to limitations imposed by the COVID-19 pandemic, we utilised the Brief Observation of Symptoms of Autism for Minimally Verbal children (BOSA-MV) for some participants, which was administered online and may not gather as accurate a picture of traits as ADOS-2. The BOSA-MV was utilised for 41% of participants with NF1 at 36 months compared to 11% at 24 months. This may explain the reduction in the percentage of children with NF1 that met autism criteria at 36 months.</AbstractText><AbstractText Label="CONCLUSIONS">By 24 months of age, the NF1 cohort show lower cognitive skills and adaptive behaviour and higher levels of autism and ADHD traits as compared to TD children. This has implications for developmental monitoring and referral for early interventions.</AbstractText><AbstractText Label="TRIAL REGISTRATION">Not applicable.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Slevin</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kehinde</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Begum-Ali</LastName><ForeName>Jannath</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Brain and Cognitive Development and Department of Psychological Sciences, Birkbeck, University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>Ceri</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Psychology, Communication and Human Neuroscience, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burkitt-Wright</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harrington Building, Royal Manchester Children's Hospital, Oxford Rd, Manchester, M13 9WL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Mark H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Centre for Brain and Cognitive Development and Department of Psychological Sciences, Birkbeck, University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasco</LastName><ForeName>Greg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Psychology Department, Institute of Psychiatry, King's College London, Psychology &amp; Neuroscience, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charman</LastName><ForeName>Tony</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Psychology Department, Institute of Psychiatry, King's College London, Psychology &amp; Neuroscience, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Emily J H</ForeName><Initials>EJH</Initials><AffiliationInfo><Affiliation>Centre for Brain and Cognitive Development and Department of Psychological Sciences, Birkbeck, University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Shruti</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. shruti.garg@manchester.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harrington Building, Royal Manchester Children's Hospital, Oxford Rd, Manchester, M13 9WL, UK. shruti.garg@manchester.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>EDEN-STAARS team</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Autism</MedlineTA><NlmUniqueID>101534222</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009456" MajorTopicYN="Y">Neurofibromatosis 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="Y">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002657" MajorTopicYN="N">Child Development</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001289" MajorTopicYN="N">Attention Deficit Disorder with Hyperactivity</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001321" MajorTopicYN="N">Autistic Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADHD</Keyword><Keyword MajorTopicYN="N">Autism</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Cohort</Keyword><Keyword MajorTopicYN="N">NF1</Keyword><Keyword MajorTopicYN="N">Neurofibromatosis</Keyword><Keyword MajorTopicYN="N">Trajectories</Keyword></KeywordList><CoiStatement>TC has served as a paid consultant to F. Hoffmann-La Roche Ltd. and Servier; and has received royalties from Sage Publications and Guilford Publications. The other authors have no conflicts of interest to disclose.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Agyapong</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bazelmans</LastName><ForeName>Tessel</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dafner</LastName><ForeName>Leila</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ersoy</LastName><ForeName>Mutluhan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gliga</LastName><ForeName>Teodora</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goodwin</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haartsen</LastName><ForeName>Rianne</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Halkola</LastName><ForeName>Hanna</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hendry</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holman</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalwarowsky</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lloyd-Fox</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mason</LastName><ForeName>Luke</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Narvekar</LastName><ForeName>Nisha</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pirazzoli</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taylor</LastName><ForeName>Chloë</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vassallo</LastName><ForeName>Grace</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eelloo</LastName><ForeName>Judith</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>D Gareth</ForeName><Initials>DG</Initials></Investigator><Investigator ValidYN="Y"><LastName>West</LastName><ForeName>Siobhan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hupton</LastName><ForeName>Eileen</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robinson</LastName><ForeName>Louise</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lakhani</LastName><ForeName>Neeta</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilson</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Osio</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw-Smith</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canham</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharif</LastName><ForeName>Saba</ForeName><Initials>S</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>23</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39407332</ArticleId><ArticleId IdType="pmc">PMC11481376</ArticleId><ArticleId IdType="doi">10.1186/s13229-024-00621-5</ArticleId><ArticleId IdType="pii">10.1186/s13229-024-00621-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010;152A(2):327–32. 10.1002/ajmg.a.33139.</Citation><ArticleIdList><ArticleId IdType="pubmed">20082463</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein-Tasman BP, Janke KM, Luo W, Casnar CL, Hunter SJ, Tonsgard J, et al. Cognitive and psychosocial phenotype of young children with neurofibromatosis-1. J Int Neuropsychol Soc. 2014;20(1):88–98. 10.1017/S1355617713001227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4249943</ArticleId><ArticleId IdType="pubmed">24229851</ArticleId></ArticleIdList></Reference><Reference><Citation>Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021;23(8):1506–13. 10.1038/s41436-021-01170-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354850</ArticleId><ArticleId IdType="pubmed">34012067</ArticleId></ArticleIdList></Reference><Reference><Citation>Brei NG, Klein-Tasman BP, Schwarz GN, Casnar CL. Language in young children with neurofibromatosis-1: relations to functional communication, attention, and social functioning. Res Dev Disabil. 2014;35(10):2495–504. 10.1016/j.ridd.2014.06.016.</Citation><ArticleIdList><ArticleId IdType="pubmed">24995687</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman SL, Shores A, North KN. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology. 2005;65(7):1037–44. 10.1212/01.wnl.0000179303.72345.ce.</Citation><ArticleIdList><ArticleId IdType="pubmed">16217056</ArticleId></ArticleIdList></Reference><Reference><Citation>Chisholm AK, Anderson VA, Pride NA, Malarbi S, North KN, Payne JM. Social function and autism spectrum disorder in children and adults with neurofibromatosis type 1: a systematic review and meta-analysis. Neuropsychol Rev. 2018;28(3):317–40. 10.1007/s11065-018-9380-x.</Citation><ArticleIdList><ArticleId IdType="pubmed">30097761</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg S, Lehtonen A, Huson SM, Emsley R, Trump D, Evans DG, et al. Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study. Dev Med Child Neurol. 2013;55(2):139–45. 10.1111/dmcn.12043.</Citation><ArticleIdList><ArticleId IdType="pubmed">23163236</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehtonen A, Howie E, Trump D, Huson SM. Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence. Dev Med Child Neurol. 2013;55(2):111–25. 10.1111/j.1469-8749.2012.04399.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">22934576</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaussart-Corbat ML, Barbarot S, Farges D, Martin L, Roy A. Executive functions in preschool-aged children with neurofibromatosis type 1: Value for early assessment. J Clin Exp Neuropsychol. 2021;43(2):163–75. 10.1080/13803395.2021.1893277.</Citation><ArticleIdList><ArticleId IdType="pubmed">33685350</ArticleId></ArticleIdList></Reference><Reference><Citation>Casnar CL, Klein-Tasman BP. Parent and teacher perspectives on emerging executive functioning in preschoolers with neurofibromatosis type 1: comparison to unaffected children and lab-based measures. J Pediatr Psychol. 2017;42(2):198–207. 10.1093/jpepsy/jsw042.</Citation><ArticleIdList><ArticleId IdType="pubmed">27189686</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzo J, Barton B, Acosta MT, North K. Mental, motor, and language development of toddlers with neurofibromatosis type 1. J Pediatr. 2011;158(4):660–5. 10.1016/j.jpeds.2010.10.001.</Citation><ArticleIdList><ArticleId IdType="pubmed">21094952</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzo J, Barton B, Arnold SS, North KN. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study. J Pediatr. 2013;163(5):1479–83. 10.1016/j.jpeds.2013.06.038.</Citation><ArticleIdList><ArticleId IdType="pubmed">23910685</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardej SK, Glad DM, Casnar CL, Janke KM, Klein-Tasman BP. Longitudinal investigation of early motor development in neurofibromatosis type 1. J Pediatr Psychol. 2022;47(2):180–8. 10.1093/jpepsy/jsab090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9020479</ArticleId><ArticleId IdType="pubmed">34664663</ArticleId></ArticleIdList></Reference><Reference><Citation>Soucy EA, Gao F, Gutmann DH, Dunn CM. Developmental delays in children with neurofibromatosis type 1. J Child Neurol. 2012;27(5):641–4. 10.1177/0883073811423974.</Citation><ArticleIdList><ArticleId IdType="pubmed">22190506</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg S, Wan MW, Begum-Ali J, Kolesnik-Taylor A, Green J, Johnson MH, et al. Early developmental trajectories in infants with neurofibromatosis 1. Front Psychol. 2022;13:795951. 10.3389/fpsyg.2022.795951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9355323</ArticleId><ArticleId IdType="pubmed">35936291</ArticleId></ArticleIdList></Reference><Reference><Citation>Green J, Pickles A, Pasco G, et al. Randomised trial of a parent-mediated intervention for infants at high risk for autism: longitudinal outcomes to age 3 years. J Child Psychol Psychiatry. 2017;58(12):1330–40. 10.1111/jcpp.12728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5724485</ArticleId><ArticleId IdType="pubmed">28393350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzo J, Barton B, Arnold SS, North KN. Developmental trajectories of young children with neurofibromatosis type 1: a longitudinal study from 21 to 40 months of age. J Pediatr. 2015;166(4):1006–12. 10.1016/j.jpeds.2014.12.012.</Citation><ArticleIdList><ArticleId IdType="pubmed">25598303</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessel LE, Gao F, Gutmann DH, Dunn CM. Longitudinal analysis of developmental delays in children with neurofibromatosis type 1. J Child Neurol. 2013;28(12):1689–93. 10.1177/0883073812462885.</Citation><ArticleIdList><ArticleId IdType="pubmed">23112244</ArticleId></ArticleIdList></Reference><Reference><Citation>Begum-Ali J, Kolesnik-Taylor A, Quiroz I, Mason L, Garg S, Green J, et al. Early differences in auditory processing relate to autism spectrum disorder traits in infants with neurofibromatosis type I. J Neurodev Disord. 2021;13(1):22. 10.1186/s11689-021-09364-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8161667</ArticleId><ArticleId IdType="pubmed">34049498</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter Leno V, Begum-Ali J, Goodwin A, Mason L, Pasco G, Pickles A, et al. Infant excitation/inhibition balance interacts with executive attention to predict autistic traits in childhood. Mol Autism. 2022;13(1):46. 10.1186/s13229-022-00526-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9733024</ArticleId><ArticleId IdType="pubmed">36482366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolesnik AM, Jones EJH, Garg S, et al. Early development of infants with neurofibromatosis type 1: a case series. Mol Autism. 2017;8:62. 10.1186/s13229-017-0178-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5701449</ArticleId><ArticleId IdType="pubmed">29204259</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsabbagh M, Fernandes J, Webb SJ, et al. Disengagement of visual attention in infancy is associated with emerging autism in toddlerhood. Biol Psychiatry. 2013;74(3):189–94. 10.1016/j.biopsych.2012.11.030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715700</ArticleId><ArticleId IdType="pubmed">23374640</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsabbagh M, Volein A, Csibra G, et al. Neural correlates of eye gaze processing in the infant broader autism phenotype. Biol Psychiatry. 2009;65(1):31–8. 10.1016/j.biopsych.2008.09.034.</Citation><ArticleIdList><ArticleId IdType="pubmed">19064038</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson M, Kiernan K, McLanahan S. Maternal education, changing family circumstances, and children’s skill development in the United States and UK. Ann Am Acad Pol Soc Sci. 2017;674(1):59–84. 10.1177/0002716217729471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5857959</ArticleId><ArticleId IdType="pubmed">29563643</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullen EM. Mullen scales of early learning. AGS. Circle Pines: American Guidance Service Inc.; 1995.</Citation></Reference><Reference><Citation>Sparrow SS, Cicchetti DV, Saulnier CA. Vineland Adaptive Behavior Scales, Third edition (Vineland-3). San Antonio: Pearson; 2016.</Citation></Reference><Reference><Citation>Achenbach TM, Rescorla LA. Manual for the ASEBA school-age forms and profiles. Burlington: University of Vermont Research Center for Children, Youth, &amp; Families; 2001.</Citation></Reference><Reference><Citation>Achenbach TM. DSM Guide for the ASEBA. Burlington: University of Vermont Research Center for Children, Youth, &amp; Families; 2013.</Citation></Reference><Reference><Citation>Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord. 2000;30(3):205–23.</Citation><ArticleIdList><ArticleId IdType="pubmed">11055457</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyster R, Gotham K, Guthrie W, Coffing M, Petrak R, Pierce K, et al. The autism diagnostic observation schedule-toddler module: a new module of a standardized diagnostic measure for autism spectrum disorders. J Autism Dev Disord. 2009;39(9):1305–20. 10.1007/s10803-009-0746-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2893552</ArticleId><ArticleId IdType="pubmed">19415479</ArticleId></ArticleIdList></Reference><Reference><Citation>Dow D, Holbrook A, Toolan C, McDonald N, Sterrett K, Rosen N, et al. The brief observation of symptoms of autism (BOSA): development of a new adapted assessment measure for remote telehealth administration through COVID-19 and beyond. J Autism Dev Disord. 2022;52(12):5383–94. 10.1007/s10803-021-05395-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674519</ArticleId><ArticleId IdType="pubmed">34914016</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord C, Rutter M, Le Couteur A. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24(5):659–85. 10.1007/BF02172145.</Citation><ArticleIdList><ArticleId IdType="pubmed">7814313</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord C, Storoschuk S, Rutter M, Pickles A. Using the ADI-R to diagnose autism in preschool children. Infant Ment Health J. 1993;14(3):234–52. 10.1002/1097-0355(199323)14:3%3c234::AID-IMHJ2280140308%3e3.0.CO;2-F.</Citation></Reference><Reference><Citation>Risi S, Lord C, Gotham K, Corsello C, Chrysler C, Szatmari P, et al. Combining information from multiple sources in the diagnosis of autism spectrum disorders. J Am Acad Child Adolesc Psychiatry. 2006;45(9):1094–103. 10.1097/01.chi.0000227880.42780.0e.</Citation><ArticleIdList><ArticleId IdType="pubmed">16926617</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson MH, Charman T, Pickles A, Jones EJH. Annual research review: anterior modifiers in the emergence of neurodevelopmental disorders (AMEND)-a systems neuroscience approach to common developmental disorders. J Child Psychol Psychiatry. 2021;62(5):610–30. 10.1111/jcpp.13372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8609429</ArticleId><ArticleId IdType="pubmed">33432656</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson MH, Jones EJ, Gliga T. Brain adaptation and alternative developmental trajectories. Dev Psychopathol. 2015;27(2):425–42. 10.1017/S0954579415000073.</Citation><ArticleIdList><ArticleId IdType="pubmed">25997763</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg S, Plasschaert E, Descheemaeker MJ, et al. Autism spectrum disorder profile in neurofibromatosis type I. J Autism Dev Disord. 2015;45(6):1649–57. 10.1007/s10803-014-2321-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">25475362</ArticleId></ArticleIdList></Reference><Reference><Citation>Diggs-Andrews KA, Tokuda K, Izumi Y, Zorumski CF, Wozniak DF, Gutmann DH. Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice. Ann Neurol. 2013;73(2):309–15. 10.1002/ana.23793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3608728</ArticleId><ArticleId IdType="pubmed">23225063</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluschke A, von der Hagen M, Papenhagen K, Roessner V, Beste C. Response inhibition in attention deficit disorder and neurofibromatosis type 1-clinically similar, neurophysiologically different. Sci Rep. 2017;7:43929. 10.1038/srep43929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5338250</ArticleId><ArticleId IdType="pubmed">28262833</ArticleId></ArticleIdList></Reference><Reference><Citation>Buitelaar J, Bölte S, Brandeis D, et al. Toward precision medicine in ADHD. Front Behav Neurosci. 2022;16: 900981. 10.3389/fnbeh.2022.900981.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9299434</ArticleId><ArticleId IdType="pubmed">35874653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochhar P, Arora I, Bellato A, Ropar D, Hollis C, Groom MMJ. A comparison of visual attention to pictures in the autism diagnostic observation schedule in children and adolescents with ADHD and/or autism. Front Psychiatry. 2024;15:1378593. 10.3389/fpsyt.2024.1378593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11089217</ArticleId><ArticleId IdType="pubmed">38742132</ArticleId></ArticleIdList></Reference><Reference><Citation>Salley B, Gabrielli J, Smith CM, Braun M. Do communication and social interaction skills differ across youth diagnosed with autism spectrum disorder, attention-deficit/hyperactivity disorder, or dual diagnosis? Res Autism Spectr Disord. 2015;20:58–66. 10.1016/j.rasd.2015.08.006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4709846</ArticleId><ArticleId IdType="pubmed">26779281</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanner A, Dounavi K. The Emergence of Autism Symptoms Prior to 18 Months of Age: A Systematic Literature Review. J Autism Dev Disord. 2021;51(3):973–93. 10.1007/s10803-020-04618-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7954747</ArticleId><ArticleId IdType="pubmed">32734422</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller M, Iosif AM, Hill M, Young GS, Schwichtenberg AJ, Ozonoff S. Response to name in infants developing autism spectrum disorder: a prospective study. J Pediatr. 2017;183:141-146.e1. 10.1016/j.jpeds.2016.12.071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5370582</ArticleId><ArticleId IdType="pubmed">28162768</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon RG, Watson LR. Brief report: gestures in children at risk for autism spectrum disorders. J Autism Dev Disord. 2015;45(7):2267–73. 10.1007/s10803-015-2390-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">25676685</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymann P, Northrup JB, West KL, Parladé MV, Leezenbaum NB, Iverson JM. Coordination is key: joint attention and vocalisation in infant siblings of children with autism spectrum disorder. Int J Lang Commun Disord. 2018;53(5):1007–20. 10.1111/1460-6984.12418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6156996</ArticleId><ArticleId IdType="pubmed">30079576</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg S, Heuvelman H, Huson S, Tobin H, Green J, Northern UKNFRN. Sex bias in autism spectrum disorder in neurofibromatosis type 1. J Neurodev Disord. 2016; 8:26. 10.1186/s11689-016-9159-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4980803</ArticleId><ArticleId IdType="pubmed">27516813</ArticleId></ArticleIdList></Reference><Reference><Citation>Messinger DS, Young GS, Webb SJ, Ozonoff S, Bryson SE, Carter A, et al. Early sex differences are not autism-specific: a baby siblings research consortium (BSRC) study. Mol Autism. 2015;6:32. 10.1186/s13229-015-0027-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4455973</ArticleId><ArticleId IdType="pubmed">26045943</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehrer-Sawatzki H, Cooper DN. Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants. Hum Genet. 2022;141(2):177–91. 10.1007/s00439-021-02410-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8807470</ArticleId><ArticleId IdType="pubmed">34928431</ArticleId></ArticleIdList></Reference><Reference><Citation>Biotteau M, Dejean S, Lelong S, et al. Sporadic and familial variants in nf1: an explanation of the wide variability in neurocognitive phenotype? Front Neurol. 2020;11:368. 10.3389/fneur.2020.00368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7214842</ArticleId><ArticleId IdType="pubmed">32431664</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, Allen T, Wolters PL, et al. Predictors of cognitive development in children with neurofibromatosis type 1 and plexiform neurofibromas. Dev Med Child Neurol. 2020;62(8):977–84. 10.1111/dmcn.14489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332409</ArticleId><ArticleId IdType="pubmed">32052421</ArticleId></ArticleIdList></Reference><Reference><Citation>Geoffray MM, Falissard B, Green J, et al. Autism spectrum disorder symptom profile across the RASopathies. Front Psychiatry. 2020;11:585700. 10.3389/fpsyt.2020.585700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7843573</ArticleId><ArticleId IdType="pubmed">33519543</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. American Psychiatric Association; 2013.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>